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Abstract
Background: This study examined the association of 25-hydroxyvitamin D (25(OH)D) and C-reactive protein (CRP)
with postoperative medical complications and one year mortality of elderly patients sustaining a low-energy
cervical hip fracture scheduled for surgery. We hypothesized that vitamin D deficiency and CRP in these patients
might be associated with an increased 1-year mortality.
Methods: The prospective single-center cohort study included 209 patients with a low-energy medial femoral neck
fracture; 164 women aged over 50 years and 45 men aged over 60 years. Referring to 1-year mortality and
postoperative medical complications multiple logistic regression analysis including 10 co-variables (age, sex, BMI,
ASA, creatinine, CRP, leukocytes hemoglobin, 25(OH)D, vitamin D supplementation at follow-up) was performed.
Results: Vitamin D deficiency was prevalent in 87 % of all patients. In patients with severe (<10 ng/ml) and moderate
(10–20 ng/ml) vitamin D deficiency one year mortality was 29 % and 13 %, respectively, compared to 9 % in patients
with > 20 ng/ml 25(OH)D levels (p =0.027). Patients with a mild (CRP 10–39.9 mg/l) or active inflammatory response
(CRP≥ 40 mg/l) showed a higher one year mortality of 33 % and 40 % compared to 16 % in patients with no (CRP <
10 mg/l) inflammatory response (p = 0.002). Multiple logistic regression analysis identified CRP (OR 1.01, 95 % CI 1.00-
1.02; p = 0.007), but not 25(OH)D (OR 0.97, 95 % CI 0.89-1.05; p = 0.425) as an independent predictor for one year
mortality. 20 % of patients suffered in-hospital postoperative medical complications (i.e. pneumonia, thromboembolic
events, etc.). 25(OH)D (OR 0.89, 95 % CI 0.81–0.97; p = 0.010), but not CRP (OR 1.01, 95 % CI 1.00-1.02; p = 0.139), was
identified as an independent risk factor.
Conclusion: In elderly patients with low-energy cervical hip fracture, 25(OH)D is independently associated with
postoperative medical complications and CRP is an independent predictor of one year mortality.
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Background
Hip fractures are incisive events for elderly people. Over-
all complication rates after surgery for hip fracture add
up to almost 50 % [1]. Approximately half of hip fracture
patients fall at least once within 12 months [2] after sur-
gery resulting in additional fractures in 10-20 % of these
patients [3]. Every third hip fracture patient needs to be
readmitted due to postoperative morbidity for any rea-
son within one year after surgery [2, 4]. Moreover, up to
30 % of the patients with a hip fracture die within the
first year [5] which is an excess mortality of 8-18 % at
one year compared to matching cohorts without a hip
fracture [6].
Identification of risk factors offers the chance to deter-
mine patients prone to postoperative morbidity and mor-
tality in the first year after hip fractures. Patient specific
factors as age, gender, general health status and comorbid-
ities, i.e. cardiac disease and dementia, have been identi-
fied as potential risk factors [7–9]. Apart from these
factors, routine laboratory parameters can predict mortal-
ity. Low hemoglobin, total leukocyte count and albumin,
as well as high creatinine and parathyroid hormone (PTH)
levels are associated with a higher probability of death
after one year in hip fracture patients [10].
The potential influence of serum 25-hydroxyvitamin D
(25(OH)D on mortality is discussed controversially.
Many studies demonstrated an independent inverse rela-
tionship between 25(OH)D and mortality [11–13] while
other studies did not [14, 15]. In hip fracture patients no
independent association between 25(OH)D and hospital
mortality or one year mortality was found [16, 17]. Only
limited information is available on 25(OH)D as a potential
risk factor of postoperative medical complications [16]. To
our knowledge, no information is available on CRP as a
potential predictor of one year mortality in hip fracture
patients but there is data showing no relationship between
CRP and mortality at 3 month postoperatively [18].
We hypothesized that low levels of 25(OH)D and ele-
vated levels of CRP are associated with increased post-
operative medical complications and one year mortality
of elderly patients that sustained a low-energy hip
fracture.
Methods
Ethical statement and patients
The study was approved by the local Ethics Committee
at the University of Leipzig (243-11-11072011). Written
informed consent was obtained from all patients or their
legal representative.
For this prospective single-center cohort study, all pa-
tients were enrolled from January 2011 to March 2014.
Female patients older than 50 years and male patients
older than 60 years that suffered a low-energy, medial
femoral neck fracture and were scheduled for surgery,
were included. Patients presenting with a pathologic frac-
ture or sustaining a high-energy trauma were excluded.
209 patients were enrolled, with 164 females accounting
for 79 %. Median (interquartile range; IQR) age of the pa-
tients was 81 (73-87) years. Comorbidities were assessed
according to the American Society of Anaesthesiologists
(ASA) score [19].
Surgical treatment
All patients received general anesthesia and were treated
operatively. Patients with undisplaced or minimal dis-
placed fractures (Garden I/II) were generally scheduled
for internal fixation with a dynamic hip screw (33 %)
(DHS; DePuy-Synthes, West Chester, USA). In displaced
fractures (Garden III/IV) a bipolar hemiprosthesis
(62 %) (DePuy, Warsaw, USA) was implanted. Patients
with a displaced fracture and concomitant advanced
coxarthrosis or a high functional demand received total
hip arthroplasty (5 %) (DePuy, Warsaw, USA). Final de-
cision on implant choice also considered was individual
patient characteristics.
Follow-up
Postoperative medical complications that necessitated
specific therapeutic intervention were recorded during
the stay in hospital and classified into cardiovascular,
thromboembolic, pulmonary infection, extra-pulmonary
infection and others (i.e. delirium).
At 6 and 12 months after surgery patients or their au-
thorized representative and, if necessary, their general
practitioner, were contacted by phone and asked about
walking ability and pain in the concerned hip according
to the Merle d’Aubigné score [20]. Additionally, compli-
cations and medication for osteoporosis treatment were
documented. No patient was lost during follow-up at
12 months. Two patients (1 %) refused to answer the
questions of the protocol but were still alive at one year
postoperatively. General postoperative complications
were recorded, if subsequent specific medical therapy
was necessary.
Blood samples and biochemical methods
Blood samples for routine laboratory parameters, in par-
ticular creatinine, CRP, hemoglobin and total leukocyte
count were drawn immediately after admission to the
emergency room. An additional fasting blood sample for
analysis of circulating 25(OH)D was taken between 7.00
and 10.00 am preoperatively in 70 % and postoperatively
at day 3 to 5 in 30 % of the patients. In 7 patients both
pre- and postoperative levels of 25(OH)D were analyzed
demonstrating no significant difference (preoperative 8.4
[6.3 – 17.7], postoperative 8.5 [7.4 - 14.5] mg/ml
25(OH)D; p = 0.156). Serum 25(OH)D was determined
with the LIAISON® 25-OH Vitamin D assay (DiaSorin,
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Stillwater, MN, USA). The degree of vitamin D defi-
ciency was classified as severe (<10 ng/ml), moderate
(10–19.9 ng/ml), insufficient (20–29.9 ng/ml) and nor-
mal (≥30 ng/ml) [21]. Recommendation for oral Vitamin
D (1.000 IE/day) and calcium supplementation was given
in the discharge letter for all patients. According to
Clyne and Olshaker [22] CRP levels were divided into
three groups: no inflammatory response (<10 mg/l), mild
(10–39.9 mg/l) and active inflammatory response
(≥40 mg/l).
Statistical analysis
Sample size calculation for a logistic regression model
was performed with the statistical program G-Power
(University of Düsseldorf, Germany). We estimated an
increased mortality risk of at least 60 % in subjects with
vitamin D deficiency based on observational studies [11]
and own experience. With an assumed α-error of 5 %
and a power of 80 % a total necessary sample size of 182
patients was calculated. Post hoc power analysis con-
firmed that targeted sample sizes provided 91 % power
(α = 0.05, β = 0.91) to detect a significant difference in
mortality rates of patients with severe vitamin D defi-
ciency compared to all other patients.
Normally distributed parameters were given as mean
and standard deviation (SD), for non-normally distrib-
uted parameters, median and the interquartile range
[25th–75th percentile] were used. The following statis-
tical tests were applied: Kaplan-Meier survival analysis,
log rank (Mantel-Cox), Spearman correlation, and Wil-
coxon test. Binary multivariable regression analysis was
performed with stepwise selection and inclusion of ten
co-variables: age, sex, BMI, ASA, vitamin D supplemen-
tation at hemoglobin, total leukocyte count, creatinine,
CRP and 25(OH)D. For 1-year mortality rates vitamin D
supplementation at follow-up and for postoperative
medical complications vitamin D supplementation at ad-
mission was added as a co-variable. All statistical com-
putations were performed using SPSS version 20.0
(Chicago, IL, USA). P values less than 5 % were consid-
ered as significant.
Results
At admission to hospital, normal and insufficient
25(OH)D levels were present in only 1 % and 12 % of
the patients, respectively. Moderate and severe 25(OH)D
deficiency were prevalent in 28 % and 59 % of the pa-
tients (Table 1). In the annual period the variation of
25(OH)D in the study cohort was low and variations of
monthly median values did not exceed 15 ng/ml (Fig. 1).
From February to April and September to November
25(OH)D monthly median levels of all patients were
below 10 ng/ml. At admission to hospital, only 10 % of
the patients supplemented vitamin D. This rate in-
creased to 19 % after discharge from hospital.
We found correlations of 25(OH)D with CRP (r = −0.245,
p = 0.001), age (r = −0.278, p < 0.001), and ASA score (r=
−0.267, p < 0.001). CRP only correlated weakly with the
ASA score (r = 0.155, p = 0.026) (Table 2).
Mortality after 1 year was 29 %, 13 % and 9 % for pa-
tients with severe and moderate 25(OH)D deficiency or
insufficient 25(OH)D levels, respectively. All patients with
normal 25(OH)D levels survived the first year (Fig. 2a).
The inverse relationship between 25(OH)D and mortality
was significant (p = 0.027). Dividing 25(OH)D levels into
quartiles showed similar results with a mortality rate of
6 % in the highest, 23 % and 24 % in the intermediate
quartiles and 34 % in the lowest quartile (p = 0.014). Mul-
tivariable logistic regression analysis adjusted for age, sex,
BMI, ASA score and potential confounders as creatinine,
CRP, haemoglobin, total leukocyte count, and vitamin D
supplementation at follow-up revealed no independent as-
sociation of 25(OH)D and mortality (OR 0.97, 95%CI
0.89-1.05, p = 0.425) (Table 3).
No inflammatory response (CRP < 10 mg/l) was seen
in 64 % patients, while a mild and active response was
prevalent in 24 % and 12 % of the patients (Table 1).
Kaplan-Meier survival curves demonstrate a significantly
higher mortality rate of up to 40 % for patients with
CRP levels ≥ 10 mg/l (p = 0.002) (Fig. 2b). Logistic re-
gression analysis adjusted for age, sex, BMI, ASA score
and additional potential confounders as creatinine,
Table 1 Baseline characteristics and postoperative results of all
patients
Age (years) 81 (73–87)
sex (female) 79 %
BMI 25 (22–28)
ASA I: 2 % II: 27 % III: 69 % IV:
2 %
creatinine (μmol/l) 73 (60–97)
haemoglobin (mmol/l) 7.9 (7.2-8.6)
leukocytes (exp9/l) 10.2 (8.0-13-3)
CRP (mg/l) 5.3 (1.8-15.4)






pulmonary infection 3 %
extra-pulmonary infections 4 %
other (i.e. delirium) 6 %
30-day mortality 13 %
1-year mortality 23 %
Values given as median (IQR) or as percentage
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25(OH)D, haemoglobin, total leukocyte count, and vita-
min D supplementation at follow-up revealed a signifi-
cant independent association with mortality (OR = 1.014,
95 % CI = 1.00-1.02, p = 0.007) (Table 3).
Postoperative medical complications warranting spe-
cific therapeutic intervention were seen in 20 % of all
patients. Cardiovascular and thromboembolic events
accounted for 30 % and 5 %, non-surgical infections for
37 % and miscellaneous events (i.e. delirium) for 28 % of
the complications (Table 1). Low 25(OH)D (OR 0.88,
95%CI 0.81-0.95, p = 0.002), but not high CRP (OR 1.01,
95%CI 1.00-1.02, p = 0.300) correlated with higher rates
of postoperative medical complications in an univariable
regression analysis. The multivariable model corrected for
age, sex, BMI, ASA score and additional potential con-
founders as creatinine, CRP, haemoglobin, total leukocyte
count, and vitamin D supplementation at admission con-
firmed 25(OH)D (OR 0.89, 95%CI 0.81-0.97, p = 0.010) as
an independent predictor of postoperative medical
complications, whereas no association was seen for CRP
(OR 1.01, 95 % CI 1.00-1.02, p = 0.139) (Table 4).
Discussion
In our study cohort of hip fracture patients, a high
prevalence of vitamin D deficiency was evident.
25(OH)D and one year mortality showed a significant
association, however 25(OH)D was not confirmed as an
independent predictor. Our results differ in part with a
study of Madsen et al. [17] of 562 hip fracture patients
in which 25(OH)D and mortality were not associated at
all one year after surgery. Interestingly, a significant as-
sociation of 25(OH)D and one year mortality was dem-
onstrated in matched controls, although 25(OH)D levels
did not differ between both groups. Notably, in the Mad-
sen study, median 25(OH)D levels of all patients were
two times higher (19.8 ng/ml), i.e. closer to the insuffi-
cient range than the deficient range, as was the case in
our study cohort (10.8 ng/ml). No information on
Fig. 1 Monthly variation of 25(OH) D levels (median, 95 % CI)
Table 2 Correlation of age, ASA-classification, CRP and 25(OH)D
Age (years) ASA CRP (mg/l) 25 (OH)D (ng/ml)
Age (years) correlation (rho r) 1.000 0.322 0.34 −0.278
significance (p) <0.001* 0.623 <0.001*
ASA correlation (rho r) 0.322 1.000 0.155 −0.267
significance (p) <0.001* 0.026* <0.001*
CRP (mg/l) correlation (rho r) 0.034 0.155 1.000 −0.245
significance (p) 0.623 0.026* 0.001*
25 (OH)D (ng/ml) correlation (rho r) −0.278 −0.267 −0.245 1.000
significance (p) <0.001* <0.001* 0.001*
*p < 0.05
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vitamin D medication of the patients was given which
could explain the substantial difference of 25(OH)D
levels to our study. In our patients, oral supplementation
of vitamin D was recorded in 19 % one year after surgery
compared to 10 % preoperatively. Consequently, this low
vitamin D substitution rate suggests low, but stable
levels of 25(OH)D within the observation period, be-
cause monthly variations of 25(OH)D were small, not
exceeding 15 ng/ml. Our assumption is confirmed by a
large population based cohort study demonstrating that
baseline 25(OH)D differed marginally over 5 years [12].
Nevertheless, 25(OH)D was not an independent pre-
dictor of one year mortality in our study. Confounding
factors potentially influenced 25(OH)D levels and may
explain this result. Systemic inflammation has been re-
ported to lower circulating 25(OH)D [23]. Consequently,
patients with a marked inflammation might be falsely
identified as vitamin D deficient. In fact, our study dem-
onstrated an inverse association between 25(OH)D and
CRP, an established indicator of systemic inflammation.
However, exclusion of CRP in the multivariable regres-
sion model did not alter the role of 25(OH)D, demon-
strating no independent association with one year
mortality. Postoperative fluid shifts also represent a po-
tential confounder of 25(OH)D measurements [24]. In
our study, most of the blood samples for analysis of
25(OH)D were taken preoperatively. Additionally, pre-
and postoperative analysis of 25(OH)D samples in the
same patients did not differ significantly in our study.
The association of 25(OH)D with age as well as with the
ASA score which both are independent predictors of
one year mortality, indicates that 25(OH)D might be
regarded as a marker of general health status and thus
explain its role as an overall, but not independent pre-
dictor of one year mortality. This is supported by inter-
ventional trails that lack clear evidence of 25(OH)D being
a causal factor of increased mortality. A recent random-
ized double-blind, placebo-controlled trail, showed that
supplementation of vitamin D in critically ill patients
failed to reduce hospital or 6 months mortality [25].
In contrast to one year mortality, we identified
25(OH)D at admission to hospital as an independent
predictor of postoperative medical complications which
is in line with the majority of surgical outcome studies
[26]. This result is also confirmed by several studies
exhibiting an association between vitamin D deficiency
and increased susceptibility to infections [27, 28].
Fig. 2 Kaplan Meier survival curves of 209 patients with hip fracture
for serum 25(OH)D a and CRP b
Table 3 Unadjusted and adjusted risk factors influencing one







age 1.11 (1.06-1.16) <0.001* 1.10 (1.04-1.18) 0.002*
sex 1.81 (0.75-4.36) 0.187 2.05 (0.57-7.43) 0.273
BMI 1.02 (0.96-1.08) 0.569 1.03 (0.96-1.11) 0.412
ASA 7.83 (2.76-22.21) <0.001* 3.59 (1.04-
12.33)
0.043*
creatinine 1.01 (1.00-1.01) 0.105 1.01 (1.00-1.02) 0.022*
CRP 1.01 (1.01-1.02) <0.001* 1.01 (1.00-1.02) 0.007*
leukocytes 1.04 (0.97-1.11) 0.268 1.02 (0.98-1.06) 0.375
hemoglobine 0.81 (0.59-1.09) 0.166 0.99 (0.68-1.43) 0.946
vitamin D at
follow-up
0.43 (0.16-1.16) 0.096 0.34 (0.07-1.54) 0.160
25(OH)D 0.90 (0.84-0.96) 0.003* 0.97 (0.89-1.05) 0.425
Age, sex, BMI, ASA and blood test parameters at admission, vitamin D
supplementation at follow-up (OR odds ratio, CI confidence interval). R2
(Nagelkerke) = 0.399. * p < 0.05.
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Indeed, a meta-analysis identified vitamin D deficiency
as a potential risk factor for increased infection rates
and sepsis in critically ill patients [29]. Vitamin D defi-
ciency may also be a potential cardiovascular risk factor
and cause myocardial structural changes [30]. However,
recent randomized double-blind, placebo-controlled trails
did not confirm that supplementation of vitamin D had
any beneficial effects on cardiovascular risk factors [31,
32]. In hip fracture patients, Fisher et al. [16] did not find
an association between low 25(OH)D levels and postoper-
ative complications in a study which did not consider
medical complications apart from cardiac incidents.
Our study revealed that an elevated CRP at admission
to hospital is an independent risk factor for one year
mortality, but not postoperative medical complications.
Accordingly, in a longitudinal study of 1044 elderly
women aged 75 years and older at inclusion elevated levels
of CRP predict higher mortality [33]. Here, in addition to
CRP, age, ASA score and creatinine were identified as in-
dependent predictors of one year mortality. This is in ac-
cordance to other authors demonstrating that age and
renal dysfunction independently are associated with in-
creased 3 months [18] and 12 months [34] mortality, re-
spectively. However, Mosfeldt et al. [18] found no
association of CRP and mortality after 3 months in hip
fracture patients, although CRP tended to be higher in de-
ceased patients.
Our study is limited by its design which does not allow
a causal conclusion. Furthermore, blood samples for
25(OH)D analysis were taken at different time points, al-
though pre- and postoperative 25(OH)D levels of the
same patients did not vary. Despite a priori and post hoc
power analysis indicated sufficient power of this study,
the number of patients might be too small to identify a
potentially independent association of 25(OH)D with 1-
year mortality. In addition, albumin und PTH, two po-
tential confounding factors influencing mortality and
morbidity [9], were not determined, thus impeding the
interpretation of results. Also, potential clinical con-
founders as functional and cognitive aspects were not
addressed [7–9].
Conclusion
In conclusion, this study demonstrates that preopera-
tively elevated CRP levels are independently associated
with increased one year mortality and 25(OH)D is an in-
dependent predictor of postoperative in-hospital medical
complications. These biochemical parameters might help
to identify elderly patients with a femoral neck fracture
being at risk for postoperative complications or death
within one year after surgery.
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Table 4 Unadjusted and adjusted risk factors influencing postoperative medical compliactions in hip fracture patients in uni- and
multivariable logistic regression models
Unadjusted OR (95 % CI) p-value Adjusted OR (95 % CI) p-value
age 1.07 (1.03 – 1.11) 0.002* 1.04 (0.99 – 1.10) 0.137
sex 1.05 (0.46 – 2.38) 0.914 0.72 (0.23 – 2.21) 0.563
BMI 0.97 (0.90 – 1.04) 0.360 0.98 (0.90 – 1.06) 0.564
ASA 5.61 (2.15 – 14.63) <0.001* 2.84 (0.92 – 8.84) 0.071
creatinine 1.01 (1.00 – 1.02) 0.490 1.02 (1.01 – 1.03) 0.005*
CRP 1.01 (1.00 – 1.02) 0.300 1.01 (1.00 – 1.02) 0.139
leukocytes 1.02 (0.99 – 1.05) 0.250 1.02 (0.99 – 1.04) 0.315
hemoglobine 0.82 (0.60 – 1.12) 0.211 1.07 (0.75 – 1.53) 0.709
vitamin D at admission 1.63 (0.59 – 4.49) 0.340 5.85 (1.03 – 33.23) 0.046*
25(OH)D 0.88 (0.81 – 0.95) 0.002* 0.89 (0.81 – 0.97) 0.010*
Age, sex, BMI, ASA and blood test parameters and vitamin D supplementation at admission (OR odds ratio, CI confidence interval). R2 (Nagelkerke) = 0.321
* p < 0.05
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